DEUTSCHE BANK AG\
BankPosition in CATX — Perspective Therapeutics, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in CATX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$221,689
+$72,516 QoQ
Shares Held
53,163
-2.0% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $5,242,610,770 across 81 Medical Devices names. CATX ranks #60 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
19,002,414 | $1,646,559,166 | |
| 2 | ABT |
Abbott Laboratories
|
14,091,704 | $1,446,795,239 | |
| 3 | EW |
Edwards Lifesciences Corp
|
6,055,023 | $484,886,235 | |
| 4 | BSX |
Boston Scientific Corp
|
6,653,275 | $417,493,000 | |
| 5 | SYK |
Stryker Corp
|
1,177,223 | $386,823,699 | |
| 6 | DXCM |
Dexcom Inc
|
3,392,733 | $213,063,626 | |
| 7 | STE |
STERIS plc
|
583,096 | $128,940,016 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
1,691,185 | $120,378,541 |
All Filings in CATX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $221,689 | 53,163 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $149,173 | 54,245 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $175,362 | 51,126 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $151,566 | 44,060 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $95,866 | 45,008 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $148,586 | 46,579 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $353,226 | 26,459 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $9,451 | 948 | Shares | Defined | 2025-06-12 | |
| No filing history on record for this holder in this stock. | ||||||